Aaron Jennings has been through quite a journey with his health and after another surgery 3 weeks ago, he remains strong and healthy and is enjoying time as a father and husband. His story is pretty unique as he's been able to use some of the products his company makes in his latest surgery as well as be on the forefront of medical innovation by staying in touch with his industry connections.
In a retrospective study of patients undergoing cranioplasty using OSSDSIGN Cranial, 96,7% of patients treated showed no signs of post-operative complications leading to implant
removal at an average follow-up time of 9,5 months. This indicates that OSSDSIGN Cranial may provide a better, more permanent solution for cranioplasty, even in
a complex patient population.
Professors Håkan Engqvist and Jöns Hillborn tell the story of how ceramic materials and polymers can be used to regenerate bone tissue.
We will be exhibiting at these meetings during 2016. Come and talk to us and find out more about our commitment to improve outcomes in cranioplasty and reconstructive facial surgery.
Clinical publication in Plastic and Reconstructive Surgery - Global Open, showing long-term outcome of the use of OSSDSIGN Cranial PSI for hemicraniectomy. See link for full text open access at PRS Global Open.
(Plastic and Reconstructive Surgery - Global Open:August 2015 - Volume 3 - Issue 8 - p e491doi: 10.1097/GOX.0000000000000467)
Uppsala, Sweden 27 January 2016 - OssDsign AB, a Swedish designer and manufacturer of innovative implants and technology for bone regeneration, today announced that the company has received CE Mark approval for its bio-ceramic burr hole plug - Cranioplug. The product will complement OssDsign's lead products OSSDSIGN Cranial and OSSDSIGN Facial, which are available in Germany, the UK, and the Nordic countries, with further market expansion ongoing.
UPPSALA - November 4, 2015. OssDsign AB today announced that it has successfully raised SEK 93 million (EUR 9.6 million), in a new equity financing. The financing is led by the new investors SEB Venture Capital and Fouriertransform with continued investment from Karolinska Development. The proceeds will be used for the market expansion of OssDsign's product line of unique craniofacial implants based on an innovative material technology with excellent biological and biomechanical properties.